DK0758241T3 - Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser - Google Patents

Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser

Info

Publication number
DK0758241T3
DK0758241T3 DK95914495T DK95914495T DK0758241T3 DK 0758241 T3 DK0758241 T3 DK 0758241T3 DK 95914495 T DK95914495 T DK 95914495T DK 95914495 T DK95914495 T DK 95914495T DK 0758241 T3 DK0758241 T3 DK 0758241T3
Authority
DK
Denmark
Prior art keywords
migration
acid derivatives
pct
dentures
bisphosphonic acid
Prior art date
Application number
DK95914495T
Other languages
Danish (da)
English (en)
Inventor
Allen E Goodship
John Kenwright
Jonathan Green
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0758241T3 publication Critical patent/DK0758241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
DK95914495T 1994-05-04 1995-04-24 Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser DK0758241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408775A GB9408775D0 (en) 1994-05-04 1994-05-04 Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
PCT/IB1995/000288 WO1995030421A1 (en) 1994-05-04 1995-04-24 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Publications (1)

Publication Number Publication Date
DK0758241T3 true DK0758241T3 (da) 2002-09-23

Family

ID=10754497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914495T DK0758241T3 (da) 1994-05-04 1995-04-24 Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser

Country Status (18)

Country Link
US (1) US5965547A (fi)
EP (1) EP0758241B1 (fi)
JP (1) JPH09512816A (fi)
AT (1) ATE218350T1 (fi)
AU (1) AU693541B2 (fi)
DE (1) DE69526937T2 (fi)
DK (1) DK0758241T3 (fi)
ES (1) ES2177642T3 (fi)
FI (1) FI118590B (fi)
GB (1) GB9408775D0 (fi)
HU (1) HUT74984A (fi)
IL (1) IL113566A (fi)
NO (1) NO310057B1 (fi)
NZ (1) NZ283430A (fi)
PT (1) PT758241E (fi)
TW (1) TW458779B (fi)
WO (1) WO1995030421A1 (fi)
ZA (1) ZA953537B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
GB2336311A (en) * 1998-04-15 1999-10-20 Merck & Co Inc Bisphosphonate Dosing Regimen
US6137012A (en) 1998-10-13 2000-10-24 E. I. Du Pont De Nemours And Company Phosphole and diphosphole ligands for catalysis
DK1135140T3 (da) * 1998-12-04 2005-12-19 Roche Diagnostics Gmbh Ibandronsyre til fremme af osseointegration af endoproteser
WO2000047214A1 (en) * 1999-02-09 2000-08-17 Sloan-Kettering Institute For Cancer Research Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
US6692758B1 (en) * 1999-08-02 2004-02-17 Toray Industries, Inc. Insertion stabilizers for implants
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
RU2288722C2 (ru) 2000-06-20 2006-12-10 Новартис Аг Способ введения бисфосфонатов
ATE304856T1 (de) * 2000-06-20 2005-10-15 Novartis Pharma Gmbh Methode zur verabreichung von biphosphonaten
AU2001287260A1 (en) * 2000-07-12 2002-01-21 Ecole Polytechnique Federale De Lausanne (Epfl) Active biocoating for bone implant
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
CN100551377C (zh) * 2002-05-10 2009-10-21 弗·哈夫曼-拉罗切有限公司 用于治疗和预防骨质疏松症的二膦酸
JP2006500402A (ja) * 2002-09-16 2006-01-05 ノバルティス　アクチエンゲゼルシャフト 股関節骨折後における二次骨折の予防または低減化方法
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
WO2008059059A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
EP1958649A1 (en) * 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor
US20100144679A1 (en) * 2007-03-21 2010-06-10 Duke University Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
WO2008152518A2 (en) * 2007-05-16 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of risedronic acid or risedronate sodium
WO2011028737A2 (en) 2009-09-01 2011-03-10 Duke University Bisphosphonate compositions and methods for treating heart failure
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
EP2780021A4 (en) 2011-11-16 2015-08-05 Univ Duke BISPHOSPHONATE COMPOSITIONS AND METHODS FOR TREATING AND / OR REDUCING HEART FAILURE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
IL84497A (en) * 1986-11-21 1994-10-21 Ciba Geigy Ag History 2-) Imidazol-1-yl (ethane-1,1-diphosphonic acid, their preparation and pharmaceutical preparations containing them
JPH05163150A (ja) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc アテローム性動脈硬化症の抑制・治療剤
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices

Also Published As

Publication number Publication date
US5965547A (en) 1999-10-12
ES2177642T3 (es) 2002-12-16
WO1995030421A1 (en) 1995-11-16
NZ283430A (en) 2000-06-23
NO964486L (no) 1996-10-22
FI964332A (fi) 1996-10-28
AU693541B2 (en) 1998-07-02
ATE218350T1 (de) 2002-06-15
EP0758241B1 (en) 2002-06-05
TW458779B (en) 2001-10-11
FI964332A0 (fi) 1996-10-28
AU2146695A (en) 1995-11-29
DE69526937T2 (de) 2003-01-02
NO964486D0 (no) 1996-10-22
NO310057B1 (no) 2001-05-14
JPH09512816A (ja) 1997-12-22
HU9603042D0 (en) 1997-01-28
ZA953537B (en) 1995-11-06
IL113566A (en) 2002-05-23
FI118590B (fi) 2008-01-15
HUT74984A (en) 1997-03-28
EP0758241A1 (en) 1997-02-19
IL113566A0 (en) 1995-08-31
GB9408775D0 (en) 1994-06-22
PT758241E (pt) 2002-10-31
DE69526937D1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
IS2034B (is) Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
IL116083A0 (en) Liquid pharmaceutical compositions containing ondansetron and their use
ES2196079T3 (es) Procedimiento de fabricacion de unidades posologicas por medio de una granulacion por via humeda.
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR9509975A (pt) Formulação farmacêutica
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling